Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Total Non-Current Liabilities (2017 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) posted Total Non-Current Liabilities of $123.99 million for Q2 2026, up 7.1% from $115.71 million a year earlier and up 7.1% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Crinetics Pharmaceuticals' Total Non-Current Liabilities came in at $130.93 million, up 20.2% from FY2024.

  • Annual Total Non-Current Liabilities has increased for seven consecutive years, with a five-year compound annual growth rate of 55.3% (FY2020 to FY2025).
  • In prior years, Crinetics Pharmaceuticals' Total Non-Current Liabilities was $108.96 million in FY2024 (+13.2%), $96.25 million in FY2023 (+168.5%), $35.85 million in FY2022 (+88.0%) and $19.07 million in FY2021 (+31.5%).
  • Quarterly Total Non-Current Liabilities has run from a low of $15.76 million in Q3 2021 to a high of $130.93 million in Q4 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last five quarters, with growth averaging 12.9% over the last six quarters.
  • The year-over-year growth in Total Non-Current Liabilities has ranged between 7.1% (Q2 2026) and 168.5% (Q4 2023) over the last five years.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $115.75 million (Q1 2026), $130.93 million (Q4 2025) and $120.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 123.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 123.99 Mn
Mar 31, 2026 115.75 Mn
Dec 31, 2025 130.93 Mn
Sep 30, 2025 120.97 Mn
Jun 30, 2025 115.71 Mn
Mar 31, 2025 105.56 Mn
Dec 31, 2024 108.96 Mn
Sep 30, 2024 103.88 Mn
Jun 30, 2024 104.57 Mn
Dec 31, 2023 96.25 Mn
Dec 31, 2022 35.85 Mn
Sep 30, 2022 33.51 Mn
Jun 30, 2022 35.57 Mn
Dec 31, 2021 19.07 Mn
Sep 30, 2021 15.76 Mn
Jun 30, 2021 15.48 Mn
Mar 31, 2021 14.05 Mn
Dec 31, 2020 14.50 Mn
Sep 30, 2020 13.07 Mn
Jun 30, 2020 14.31 Mn
API Access

Crinetics Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CRNX&period=max&api_key=YOUR_API_KEY